SCHRODINGER, INC.

Profile

Company Names

SCHRODINGER, INC.

Addresses

120 WEST 45TH STREET, 17TH FLOOR, NEW YORK, NY 10036

Phone Numbers

503-299-1150

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$159,824,987.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2018-11-09 
$107,824,987.00 
$115,000,000.00 
$7,175,013.00 
Equity 
3
2015-06-15 
$22,000,000.00 
$22,000,000.00 
$0.00 
Equity 
2
2012-12-11 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
1
2010-04-27 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHARLES 
 
ARDAI 
DIRECTOR
SCHRODINGER, INC.
CONY 
 
D-CRUZ 
EXECUTIVE OFFICER
SCHRODINGER, INC.   |  SUPERLUMINAL MEDICINES, INC.
JOSHUA 
 
DISTLER 
DIRECTOR
SCHRODINGER, INC.
RAMY 
 
FARID 
EXECUTIVE OFFICER, DIRECTOR
NIMBUS DISCOVERY, LLC   |  SCHRODINGER, INC.   |  MORPHIC HOLDING, LLC   |  AJAX THERAPEUTICS, INC.   |  SHOUTI INC.
RICHARD 
 
FRIESNER 
DIRECTOR
SCHRODINGER, INC.
WAYNE 
 
GUIDA 
DIRECTOR
SCHRODINGER, INC.
ROSANA 
 
KAPELLER-LIEBERMANN 
DIRECTOR
SCHRODINGER, INC.
JOEL 
 
LEBOWITZ 
EXECUTIVE OFFICER
SCHRODINGER, INC.
MICHAEL 
 
LYNTON 
DIRECTOR
SNAPCHAT INC   |  25MADISON, LLC   |  LEZEN ACQUISITION LLC   |  SCHRODINGER, INC.   |  PUSHKIN INDUSTRIES, INC.   |  WARNER MUSIC GROUP CORP.   |  SESAME, INC.   |  BOWERY FARMING INC.   |  SORA SCHOOLS, INC.   |  RIGHTWAY HEALTHCARE, INC.
MURCO 
 
RINGNALDA 
EXECUTIVE OFFICER
SCHRODINGER, INC.
LOUIS 
 
SALKIND 
DIRECTOR
SCHRODINGER, INC.
YVONNE 
 
TRAN 
EXECUTIVE OFFICER
SCHRODINGER, INC.
TIMOTHY 
 
WRIGHT 
DIRECTOR
ANTIGENICS INC /DE/   |  NEXAGE, INC.   |  AGENUS INC   |  SCHRODINGER, INC.   |  APIFIA INC.   |  DISRUPTOR BEAM, INC.   |  BOSTON ILLIQUID SECURITIES OFFERING NETWORK, INC.   |  ARCHIPELAGO ANALYTICS HOLDINGS, INC.   |  BEAMABLE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-05-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
2018-11-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
2015-06-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2012-12-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-11 
2010-05-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#